Iron Deficiency Anemia Market Report 2026

Iron Deficiency Anemia Market Overview

• Iron Deficiency Anemia market size has reached to $3.57 billion in 2025 • Expected to grow to $4.78 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Rising Nutritional Deficiencies Drive Market Growth • Market Trend: Innovative Iron Supplements Transforming The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Iron Deficiency Anemia Market?

Iron deficiency anemia is a condition in which the body lacks enough iron to produce an adequate amount of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. Iron deficiency can occur due to insufficient dietary intake, poor absorption of iron, blood loss, or increased iron needs (such as during pregnancy). The main therapy types for iron deficiency anemia are oral iron therapy, parenteral iron therapy, and red blood cell transfusion. Oral iron therapy involves taking iron supplements by mouth, such as tablets, capsules, or liquids, to increase iron levels in the body. It is distributed through hospital pharmacies, drug stores, retail pharmacies, and online pharmacies, catering to various end users, including hospitals, clinics, and home healthcare.

What Is The Iron Deficiency Anemia Market Growth Forecast?

The iron deficiency anemia market size is expected to see strong growth in the next few years. It will grow to $4.78 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising global anemia burden, increasing adoption of intravenous iron therapies, growth in geriatric population, expanding healthcare access in emerging markets, improved diagnostic and screening initiatives. Major trends in the forecast period include rising adoption of parenteral iron therapies, increasing focus on maternal and pediatric anemia management, growing use of high-dose and long-acting iron formulations, expansion of home-based iron therapy and infusion services, increasing awareness and screening programs for iron deficiency.

Global Iron Deficiency Anemia Market Segmentation

1) By Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion 2) By Distribution Channel: Hospital Pharmacy, Drug Stores and Retail Pharmacies, Online Pharmacies 3) By End Users: Hospitals, Clinics, Home Healthcare Subsegments: 1) By Oral Iron Therapy: Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide-Iron Complex, Carbonyl Iron 2) By Parenteral Iron Therapy: Iron Sucrose, Ferric Carboxymaltose, Iron Dextran, Ferumoxytol, Ferric Gluconate 3) By Red Blood Cell Transfusion: Leukocyte-Reduced Red Blood Cell Transfusion, Washed Red Blood Cell Transfusion, Irradiated Red Blood Cell Transfusion

What Is The Driver Of The Iron Deficiency Anemia Market?

The increasing cases of nutritional deficiencies are expected to propel the iron deficiency anemia market going forward. Nutritional deficiency refers to a condition that occurs when the body lacks the necessary amount of one or more essential nutrients, such as vitamins, minerals, proteins, or fats, required for optimal health. Nutritional deficiencies are on the rise due to poor dietary choices, with the widespread consumption of processed foods and food insecurity, which limits access to nutrient-dense options in lower-income populations. Iron deficiency anemia is a common form of nutritional deficiency where a lack of iron in the diet leads to a decrease in the number of red blood cells, impairing the body's ability to transport oxygen. For instance, in February 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, it is estimated that anaemia affects 40% of children aged 6–59 months, 37% of pregnant women, and 30% of women between 15 and 49 years old. Therefore, the increasing cases of nutritional deficiencies drive the iron deficiency anemia industry.

Key Players In The Global Iron Deficiency Anemia Market

Major companies operating in the iron deficiency anemia market are Sanofi S.A., Abbott Laboratories, Fresenius SE & Co. KGaA, Sandoz International GmbH, Perrigo Company, Cipla Limited, Dr. Reddy's Laboratories Limited, Cadila Healthcare Limited, Zydus Cadila, Lupin Limited, Alkem Laboratories Limited, AMAG Pharmaceuticals Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, AdvaCare Pharma LLC

Global Iron Deficiency Anemia Market Trends and Insights

Major companies operating in the iron deficiency anemia market are focusing on developing innovative solutions, such as intravenous iron injection, to provide a precise combination of nutrients that maximize absorption and enhance tolerance, effectively addressing iron deficiency. Intravenous iron injection is a medical procedure used to deliver iron directly into the bloodstream to treat iron deficiency or anemia when oral supplements are ineffective or insufficient. For instance, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, launched Redshot FCM, an intravenous iron injection formulated with ferric carboxymaltose to effectively treat iron deficiency anemia (IDA). This innovative product is suitable for both adults and children over one year old who cannot tolerate oral iron supplements. With a strong safety profile and minimal risk of anaphylaxis, Redshot FCM allows for the administration of high doses of iron in a single session, facilitating rapid improvement in hemoglobin levels. It is especially beneficial for vulnerable groups such as pregnant women, the elderly, and cancer patients.

What Are Latest Mergers And Acquisitions In The Iron Deficiency Anemia Market?

In May 2025, SteinCares, a Costa Rica-based specialty healthcare company, partnered with Pharmacosmos A/S to expand access to intravenous iron replacement therapy across Latin America. With this partnership, SteinCares and Pharmacosmos aim to increase the availability of Monofer, a treatment for iron deficiency with or without anemia, to improve clinical outcomes, enhance patient convenience through efficient therapy delivery, and support broader access across therapeutic areas such as nephrology, cardiology, onco-hematology, gastroenterology, gynecology, and obstetrics. Pharmacosmos A/S is a Denmark-based pharmaceutical company that specializes in developing, manufacturing, and marketing treatments for iron deficiency and iron deficiency anemia.

Regional Outlook

North America was the largest region in the iron deficiency anemia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Iron Deficiency Anemia Market?

The iron deficiency anemia market includes revenues earned by entities by providing services such as iron supplementation, bone marrow biopsy, complete blood count (CBC), and blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Iron Deficiency Anemia Market Report 2026?

The iron deficiency anemia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the iron deficiency anemia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.